Platinum Asset Management logo

Platinum Asset Management

Oceania, New South Wales, Australia, Sydney

Description

Platinum Asset Management is an Australian based fund manager which specialises in investing in international equities.

Investor Profile

Platinum Asset Management has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series Unknown, Series B rounds (top funding stages).
  • Majority of deals are located in Australia, United States, Germany.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.

Stage Focus

  • Post Ipo Equity (60%)
  • Series Unknown (20%)
  • Series B (20%)

Country Focus

  • Australia (40%)
  • United States (20%)
  • Germany (20%)
  • Sweden (20%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Clinical Trials
  • Oncology
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Software
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Platinum Asset Management frequently co-invest with?

Baillie Gifford
Europe, Edinburgh, City of, United Kingdom, Edinburgh
Co-Investments: 1
Altium Capital
North America, New York, United States, New York
Co-Investments: 1
Athena Capital (South Africa)
Africa, NA - South Africa, South Africa, Cape Town
Co-Investments: 1
Tenmile
Oceania, Western Australia, Australia, Perth
Co-Investments: 1
Northpond Ventures
North America, Maryland, United States, Bethesda
Co-Investments: 1
Mubadala Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Laurion Capital Management
North America, New York, United States, New York
Co-Investments: 1
Australian Ethical Investment
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Kinnevik
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 3

What are some of recent deals done by Platinum Asset Management?

Egetis Therapeutics AB

Stockholm, Stockholms Lan, Sweden

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.

Health CareMedicalPharmaceutical
Post Ipo EquitySep 30, 2024
Amount Raised: $29,523,450
SpeeDx

Sydney, New South Wales, Australia

SpeeDx is a provider of innovative multiplex and isothermal amplification solutions for clinical diagnostics.

BiotechnologyHealth DiagnosticsMedical
Series UnknownFeb 28, 2023
Amount Raised: $26,000,000
Recursion Pharmaceuticals

Salt Lake City, Utah, United States

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Artificial Intelligence (AI)BiotechnologyMachine LearningPharmaceuticalSoftwareTherapeutics
Post Ipo EquityOct 25, 2022
Amount Raised: $150,000,000
Immutep

Sydney, New South Wales, Australia

Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.

BiotechnologyClinical TrialsHealth CareOncologyPharmaceutical
Post Ipo EquityJul 9, 2019
Amount Raised: $6,925,165
BioNTech

Mainz, Rheinland-Pfalz, Germany

BioNTech is a biopharmaceutical company that develops cancer therapeutics for infectious diseases.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series BJul 9, 2019
Amount Raised: $325,000,000